Discovery Park Ltd Sets Vision to Continue Global Success For Iconic Site

From Drug Discovery Today - June 22, 2017

Discovery Park Ltd has begun a significant programme of investment to ensure the science parks continued success as a global centre for pharmaceutical R&D, technology and business.

Since taking over Discovery Park in November 2016, the new owners have carried out a full operational and strategic review. While honouring the master plan, agreed by Dover District Council in October 2014, the company has started to put their own stamp on the future development of the site.

Toby Hunter, Chief Executive for Discovery Park Ltd, said: As new owners, we felt it was essential to take time to reflect on what has been achieved at this wonderful site and how best to ensure its future success given all the challenges and opportunities ahead.

Our desire is to ensure that the world-wide reputation Sandwich has enjoyed for decades - from the 50 plus years under Pfizer to the five years as a flagship multi-business campus for science and enterprise - continues long into the future.

We have plans to invest in our science offer and enhance facilities across the park, starting with Discovery Park House, where work has begun creating new high-spec lab and write up provisions for existing tenants to expand into. We are also adding capacity for new pharmaceutical businesses.

These improvements include an initial 5m investment in improving science facilities, with 50,000 sq ft of new laboratory space being created and plans in place for a 60,000 sq ft expansion of office space.

Future investment includes a major revamp of the sites catering and conferencing offer, with plans to rebrand and refocus the on-site cafes and restaurants, providing an improved environment and ambience for on-site networking and collaboration.

Continue reading at Drug Discovery Today »